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The aim of this study was to evaluate binding potential of Mulva neglecta mucilage (MNM) with 
subsequent comparison to PVP K30. Eight batches of Diclofenac sodium tablets were prepared by wet 
granulation technique keeping different concentrations (4, 6, 8 & 10% w/w) of Mulva neglecta mucilage 
(extracted from leaves of Mulva neglecta) and PVP K30 as standard binder. The granules of formulated 
batches showed bulk density (g/mL) 0.49 ± 0.00 to 0.57 ± 0.00, tapped density (g/mL) 0.59 ± 0.01 
to 0.70 ± 0.01, Carr’s index 09.27 ± 0.95 to 19.65 ± 0.59, Hausner’s ratio 1.12 ± 0.00 to 1.24 ± 0.01 
and angle of repose 30.37 ± 2.90 °C to 36.86 ± 0.94 °C. Tablets were compressed to hardness 7.50 to  
7.95 kg/cm2. The tablets showed 0.39 ± 0.02 to 0.39 ± 0.01% friability and 7:20 to 14:00 min disintegration 
time. Granules and post-compression evaluation revealed that parameters assessed were all found to 
be within the pharmacopoeial limits. The results (hardness, disintegration and dissolution) proved that 
Mulva neglecta mucilage has better binding capacity for preparation of uncoated tablet dosage form as 
compared to PVP K30. Among all the formulations, MN-1 to MN-4 showed slow release as compared 
to PV-1 to PV-4 and thereby Mulva neglecta mucilage exhibited satisfactory drug release phenomenon 
tablets of diclofenac sodium.
Uniterms: Mulva neglecta/mucilage. Mulva neglecta/use as binder. Binders. Diclofenac sodium/tablets/
drug release.
O objetivo deste estudo foi avaliar o potencial de ligação de mucilagem de Mulva neglecta (MNM), com 
posterior comparação ao PVP K30. Oito lotes de comprimidos de diclofenaco de sódio foram preparados 
pela técnica de granulação úmida, mantendo diferentes concentrações (4, 6, 8 e 10% w/w) de mucilagem 
de Mulva neglecta (extraída de folhas de Mulva neglecta) e PVP K30 como ligante padrão. Os grânulos 
de lotes formulados mostraram densidade aparente (g/mL) 0.49 ± 0.00-0.57 ± 0.00, densidade compactada  
(g/mL) 0.59 ± 0.01-0.70 ± 0.01, índice de Carr 09.27 ± 0.95-19.65 ± 0.59, a relação de Hausner 
1.12 ± 0.00-1.24 ± 0.01 e ângulo de repouso 30.37 ± 2.90 °C a 36.86 ± 0.94 °C. Os comprimidos foram 
prensados à dureza de 7.50-7.95 kg/cm2. Os comprimidos apresentaram 0.39 ± 0.02-0.39 ± 0.01% 
friabilidade e 7:20-14:00 min de tempo de desintegração. A avaliação de grânulos e pós-compressão 
revelou que todos os parâmetros estavam dentro dos limites da farmacopeia. Os resultados (dureza, 
desintegração e dissolução) provaram que a mucilagem de Mulva neglecta tem maior capacidade de 
ligação na preparação da forma de dosagem de comprimido não revestido em relação à PVP K30. Entre 
todas as formulações, MN-1 e MN-4 mostraram liberação lenta em comparação com PV-1 e PV-4 e, 
assim, a mucilagem de Mulva neglecta exibiu liberação do fármaco satisfatória para os comprimidos 
de diclofenaco de sódio.
Unitermos: Mulva neglecta/mucilagem. Mulva neglecta/uso como aglutinante/avaliação. Aglutinantes. 
Diclofenaco de sódio/comprimidos/liberação do fármaco. 
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INTRODUCTION
Natural plant drugs and excipients have gained 
attractiveness over synthetic materials due to their non-
toxic nature, free availability and low cost (Zohra et al., 
2012). Mucilages are widely used in pharmaceutical 
preparations as thickening, disintegrating, binding, 
suspending, emulsifying, gelling and stabilizing agents 
(Malviya et al., 2010). Mulva neglecta Wallr. (Mulvaceae), 
commonly known as Mallow and locally ‘Sonchal’ in 
Mansehra, Pakistan. This is a perennial plant having leaves 
very shallowly lobed, crenate and pilose (Akcin, Ozbucak 
2006; Shah, Khan, 2006). The plant is used as food and 
to treat acne, broken bones, dermatitis, burns and throat 
infection (Imtiaz et al., 2012). Diclofenac sodium is a 
non-steroidal anti-inflammatory drug (NSAID), which 
is poorly soluble in water and freely soluble in organic 
solvent like methanol. It is commonly used as analgesic, 
antipyretic, anti-inflammatory for the long-term treatment 
of rheumatoid arthritis. Its structure is shown in Figure 1 
(Ganesh et al., 2010). 
In view of the easy availability of plant, the mucilage 
from the leaves of the plant was investigated for its use in 
tablets formulation and evaluates its efficiency as binder.
MATERIAL AND METHODS
Material
Diclofenac sodium, Avicel pH 101, Aerosil, 
magnesium stearate and PVP K30 were provided by Prays 
Pharmaceuticals (Pvt) Ltd, Islamabad, Pakistan. Mulva 
neglecta mucilage was extracted from leaves of plant 
(Mulva neglecta).
Extraction of the mucilage
Fresh Mulva neglecta plants (10 kg) were purchased 
from local market. The plant was identified by Prof. Dr. 
Jehandar Shah, Ex-Vice Chancellor, Shaheed Benazir 
Bhutto University, Sheringal (Dir Upper) Khyber 
Pakhtunkhwa, Pakistan. The specimen sample (PM-06-
12) was kept in Department of Pharmacy, University of 
Malakand, Chakdara, Dir Lower, Khyber Pakhtunkhwa, 
Pakistan. The fresh leaves of the plant were collected, 
washed with water to remove dirt and debris, and 
dried. The powdered leaves were soaked in water for 
4-5 h, boiled for 30 min and then kept aside for 1 h for 
complete release of the mucilage into water. The material 
was squeezed, to remove extraneous materials, by 
straining through a muslin cloth. The mucilage was then 
precipitated from the solution using absolute acetone. 
The precipitate was separated, dried in oven at 50 °C and 
stored in tightly closed container for future use in tablets 
formulations.
Preliminary phytochemical of mucilage
The phytochemical properties for the presence of 
carbohydrates, proteins, flavonoids, sterols, alkaloids, 
tannins, saponins, resins, phenols and terpenoids were 
determined as per standard tests (Cokate, 2010).
Physicochemical characterization
The isolated mucilage was evaluated for solubility in 
water, acetone, chloroform and ethanol in accordance with 
the official monograph specifications, swelling index, loss 
on drying, total ash and acid-insoluble ash determination 
(Patel et al., 2012).
Toxicity studies of Mulva neglecta mucilage
Toxicity studies were carried out according to the 
method of Knudsen and Curtis. The animals used in the 
toxicity studies were sanctioned by the Experimental 
protocols were in compliance with “Animals Byelaws 
2008 of the University of Malakand”. Ethical Committee 
of the Department of Pharmacy, University of Malakand 
approved the experimental protocols. The male albino rats 
of Wistar strain with average weight of 160-200 g were 
divided into different groups comprising of six animals 
in each group. The control group received normal saline 
20 mL/kg intraperitoneal (i.p). The other groups received 
500, 1000, 2000, 3000 and 4000 mg/kg of mucilage 
suspension in normal saline orally. The animals were 
observed continuously for the behavioral changes for the 
first 4 h and then observed for mortality for 48 h (Shah, 
Patel, 2010).
FIGURA 1 - Chemical structure of diclofenac sodium.
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Preparation and evaluation of granules
The compositions of tablets are given in Table 4. 
Diclofenac sodium and Avicel pH 101 were thoroughly 
mixed and the solutions of the mucilage and PVP K30 
(prepared by dispersing the mucilage and PVP K30 in 
water) of different concentrations (4, 6, 8 & 10% w/w) 
were used for moistening the powder mixture to prepare 
tablets. The wet mass was then passed through sieve No. 
16 and dried at temperature not exceeding 60 °C in hot 
air oven up to LOD NMT 5%. The dried granules were 
re-sieved through sieve No. 20. The same procedure was 
followed for preparation of granules using PVP K30 as 
binder.
Bulk density
Granules of known weight were poured in 10 ml 
graduated cylinder, bulk volume (V0) was noted and 
bulk density was calculated (g/cc) by the given formula 
(Ganesh, Sureshkumar et al. 2010):
Tapped density
The graduated cylinder (10 ml) containing known 
weight of granules was tapped on a hard surface until 
no further change in volume was observed. The tapped 
volume (VT) was noted and tapped density was calculated 
by putting values in formula, Weight of granules/ VT 
(Ganesh et al., 2010).
Compressibility index 
It was determined by Carr’s compressibility index, 
by formula:
where Td is tapped density and Bd is bulk density.
Hausner’s ratio
It is the ratio of tapped density to bulk density and 
was calculated by the following formula (Chakraverty, 
2011): 
where Td is tapped and Bd is bulk density.
Angle of repose (°)
It was determined by filling 10 g of powder in a 
funnel. Then the funnel was opened to release the powder 
on the paper to form a conical heap. The values were 
calculated by the given formula (Chakraverty, 2011).
Compression of Granules/ Preparation of tablets
The granules were then into tablets using rotary 
machine (ZP19 Rotary Tablet Press, Shanghai, China). 
Evaluation of tablets
Thickness
The thickness of a tablet can vary without any 
change in its weight. This is generally due to the difference 
of density of granules, pressure applied for compression 
and the speed of compression. The thickness of the tablets 
was determined by using a Digital Caliper (Shingala et al., 
2010).
Uniformity of weight
Twenty tablets were weighed by analytical balance 
(Sartorius BL 2105, Germany) after compression, then 
average weight and standard deviation was determined. 
Then determine the percentage of weight variation of each 
tablet by using following formula (Rahim et al., 2014).
Drug contents determination 
Tablets (10) were accurately weighed and powdered. 
Powder amount equivalent to 50 mg diclofenac sodium 
was shaken with 60 mL of methanol in a 200 mL 
volumetric flask and final volume was make up with 
methanol, 5 mL of this solution was further diluted to 
100 mL with methanol and absorbance was measured 
using spectrophotometer (UV-1601 Shimadzu, Japan) at 
276 nm. The content was determined by preparing same 
concentration of sodium diclofenac in the same solvent 
and absorbance was measured at 276 nm. The % content 
was determined by formula (Rahim et al., 2014): 
Friability 
The friability of tablets was determined using Roche 
Friabilator. Ten tablets were initially weighed (W1) and 
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transferred into the friabilator. The friabilator was operated 
at 25 rpm for 4 min, or alternatively was run up to 100 
revolutions. The tablets were weighed again (W2) and the 
% friability was calculated (Chakraverty, 2011).
where W1 = initial weight of 10 tablets, and W2 = weight 
of 10 tablets after 100 revolutions
Disintegration time
The method specified in the USP/NF (2007) was 
followed for disintegration time, medium used was 100 
mL of 0.1 N HCl maintained at temperature between 
37 ± 2 °C throughout the experiment. Five tablets were 
randomly selected from each batch and were placed 
one in each of the cylindrical tubes of the basket using 
disintegration test apparatus (DT-0607, Curio) but no 
disc was used. The time taken for each tablet to break up 
into small particles and pass out through the mesh was 
noted (Satyam et al., 2010).
In vitro dissolution studies
An in vitro release study was carried out using USP 
XXIV 8 station dissolution rate test apparatus, using 
900 mL of phosphate buffer pH 6.8 for a period of 1 h 
at 50 rpm with maintained temperature at 37 ± 0.5 °C. 
Samples (5 mL) were withdrawn at pre determined 
intervals over 1 h using a syringe filter of 0.2 micron and 
5 mL of fresh dissolution medium was replaced after each 
sampling in order to maintain sink condition The collected 
samples were analysed by spectrophotometer at 276 nm 
(Rajesh, Venkataraju, Gowda, 2009). 
FTIR studies
To study any possible interaction between drug 
and the plant mucilage used, FTIR spectroscopic 
analysis was carried out. The drug, plant mucilage 
and formulation blend (mixture containing Diclofenac 
sodium, Mulva neglecta mucilage, Avicel pH 101 and 
magnesium stearate) compatibility were studied by using 
IR spectrophotometer (Nicolet FTIR spectrophotometer, 
Thermoscientific Nicolet, USA). A small amount of 
Diclofenac sodium, plant mucilage and formulation 
blend were respectively placed directly on the germanium 
piece of the infrared spectrometer with constant pressure 
applied and data of infrared absorbance collected over 
the wave number ranged from 4000 cm-1 to 400 cm-1 and 
was expressed in cm-1 (Bobby, Wesely, Johnson et al., 
2012).
RESULTS AND DISCUSSION
Phytochemical screening
Phytochemical investigation of the isolated 
mucilage showed the presence of carbohydrates and 
flavonoids while absence of proteins, tannins, saponins, 
sterols, alkaloids and glycosides. The results are shown 
in Table I.
Organoleptic and physicochemical properties
The Organoleptic properties were found acceptable 
and are summarized in Table II. It showed the presence 
of mucilage by ruthenium red test with 10-20% yield, 
yellowish brown colour, bland taste and coarse appearance. 
The solubility analysis reveals that Mulva neglecta mucilage 
is sparingly soluble in cold water however it showed 
solubility when the temperature of water was increased. 
The mucilage was completely insoluble in the tested 
organic solvents including ethanol, chloroform, acetone 
and benzene. Physicochemical screenings indicate pH 
(1% w/w solution) of the isolated mucilage was found 
5.45 at 28 °C which indicate that this mucilage was less 
irritating in GIT and suitable for uncoated tablet. The 
moisture content, swelling index and loss on drying were 
7, 35 and 11% respectively. The total ash and acid insoluble 
ash value of MNM was found to be 0.974 ± 0.011 and 
0.013 ± 0.003% w/w respectively. Ash values reflect the 
level of adulteration of drug. Adulteration by sand or earth is 
immediately detected as the total ash is normally composed 
of inorganic mixtures of carbonates, phosphates, silicates 
and silica.
The physicochemical properties of granules of 
Mulva neglecta mucilage are shown in Table III. The 
prepared granules were evaluated for flow properties. The 
TABLE I - Phytochemical screening of Mulva neglecta mucilage
Active Constituent MNM
Carbohydrate +ve
Protein
-ve
Flavanoids +ve
Tannins
-ve
Saponins
-ve
Sterols
-ve
Alkaloids
-ve
Glycosides
-ve
+ve means Present, -ve means Absent
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Carr’s index values were found in range from 09.27 ± 0.59 
to 19.65 ± 0.59 while angle of repose values resulted were 
30.37 ± 2.90 to 36.86 ± 0.94. The results showed that 
granules have good flow properties. 
To determine the safety level of the extracted Mulva 
neglecta mucilage, acute toxicity study was carried out. In 
this study, the mucilage revealed no behavioral changes 
for first four hours and no mortality was observed in 
animal being tested. Toxicity studies showed no mortality, 
no toxic manifestations were observed and behavioural 
pattern was unaffected. The mucilage is therefore safe to 
be used in formulations.
Formulation of diclofenac sodium tablet by wet 
granulation method containing Mulva neglecta mucilage 
as a binder is shown in Table IV.
Three batches of the tablets prepared for each gum 
in different concentrations were evaluated for parameters 
like hardness (kg/cm2), friability (%), weight variation 
(%), disintegration time (min), thickness (%) and drug 
content (%). Hardness was found in range of 7.50 ± 0.63 
to 7.9 ± 0.68 kg/cm2. The friability values were in the 
range from 0.39±0.02 to 0.69 ± 0.01%, i.e. values are less 
than 1% and are in the acceptable range. Weight variation 
(200.80 ± 3.24 to 202.15 ± 1.32%) were within limit 
(±7.5%), disintegration time was less than 15 min fulfilling 
the pharmacopoeial limits for uncoated tablets and the 
drug content ranged from 99.44 ± 0.70 to 100.99 ± 1.10 
(limit is 90-110%). Mulva neglecta based tablets showed 
increase in hardness as compared to PVP K30 as binder. 
Rapid disintegration was observed in PVP K30 containing 
batches of tablets when compared with Mulva neglecta as 
binder. All these results are summarized in Table V.
In vitro dissolution studies
In vitro release studies was carried out using USP 
XXIV 8 station dissolution rate test apparatus using 
900 mL of phosphate buffer (pH 6.8) for a period of 1 h at 
50 rpm and the temperature was maintained at 37 ± 1 °C. 
By withdrawing samples each of 5 mL at 10 min intervals 
over 1 h and analyzed using spectrophotometer at 276 
nm. It is shown in the dissolution plot that MN-1 and 
TABLE II - Organoleptic properties of Mulva neglecta mucilage
Parameters Results
Test for mucilage (Ruthenium Red test) +ve
Yield (%) 10-20
Color Yellowish Brown
Taste Bland
Texture Moderately coarse
Solubility Sparingly Soluble in 
cold water, soluble 
in hot water forming 
viscous colloidal 
solution, insoluble in 
ethanol, chloroform, 
acetone and benzene
Moisture content (%) 7
Swelling index (%) 35
pH (1% w/w solution) at 28°C 5.45
Viscosity (1% w/w solution) m Pas 3.80
Loss on drying (%) 11
Total ash (%) 0.974 ± 0.011
Acid insoluble ash (%) 0.013 ± 0.003
All values are mean ± S.D. for n=3
TABLE III - Physicochemical properties of granules
Formulations 
with Code
Parameters
Bulk density 
(g/mL)
Tapped density 
(g/mL) Carr’s index Hausner’s ratio
Angle Repose 
(°)
MN-1 0.49 ± 0.00 0.59 ± 0.01 16.19 ± 0.53 1.18 ± 0.00 31.30 ± 0.12
MN-2 0.53 ± 0.01 0.60 ± 0.00 10.96 ± 0.01 1.12 ± 0.00 34.76 ± 0.04
MN-3 0.56 ± 0.00 0.63 ± 0.00 10.98 ± 0.01 1.12 ± 0.00 35.14 ± 0.24
MN-4 0.57 ± 0.00 0.63 ± 0.01 09.27 ± 0.59 1.09 ± 0.01 32.10 ± 0.31
PV-1 0.52 ± 0.01 0.59 ± 0.00 12.00 ± 0.20 1.13 ± 0.01 33.44 ± 1.06
PV-2 0.57 ± 0.00 0.70 ± 0.01 19.65 ± 0.59 1.24 ± 0.00 36.86 ± 0.94
PV-3 0.54 ± 0.07 0.61 ± 0.01 10.00 ± 0.13 1.12 ± 0.01 32.43 ± 1.03
PV-4 0.56 ± 0.01 0.64 ± 0.03 11.99 ± 0.51 1.13 ± 0.01 30.37 ± 2.90
All values represent mean ± S.D, n = 3. Key: S.D means standard deviation
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MN-2 released 95.21% and 76.88% respectively at the 
end of 30 min, and MN-3 and MN-4 released 78.11% and 
68.47% respectively at the end of 50 min. PV-1 and PV-2 
released 99.62% and 86.99% respectively at the end of 
30 min while batches PV-3 and PV-4 released 94.80% 
and 89.26% respectively at the end of 50 min. All the 
results of in vitro release of diclofenac sodium tablets are 
represented in Table VI.
The data showed that increase in concentrations of 
binder retard the rate of dissolution of drug from tablets. 
TABLE IV - Formulation of diclofenac sodium tablets by wet granulation method
Ingredients (mg) MN-1 MN-2 MN-3 MN-4 PV-1 PV-2 PV-3 PV-4
Diclofenac sodium 50 50 50 50 50 50 50 50
Avicel pH 101 138 133 128 123 138 133 128 123
Aerosil 4 4 4 4 4 4 4 4
MNM 5 10 15 20 --- --- --- ---
PVP K30 --- --- --- --- 5 10 15 20
Magnesium stearate 3 3 3 3 3 3 3 3
Distilled water q.s q.s q.s q.s q.s q.s q.s q.s
Total weight 200 200 200 200 200 200 200 200
TABLE V - Evaluation of diclofenac sodium tablets
Formulations Hardness (kg/cm2)
Friability 
(%)
Weight variation 
(%)
D. Time 
(min)
Thickness 
(mm)
Assay 
(%)
MN-1 7.50 ± 0.63 0.69 ± 0.01 200.80 ± 3.24 7.20 4.32 ± 1.04 99.44 ± 0.70
MN-2 7.88 ± 0.52 0.54 ± 0.03 200.30 ± 3.15 9.25 4.32 ± 1.08 100.00 ± 1.16
MN-3 7.95 ± 0.68 0.42 ± 0.04 200.80 ± 3.22 11.05 4.31 ± 1.12 100.34 ± 1.21
MN-4 7.91 ± 0.45 0.39 ± 0.02 200.90 ± 3.14 14.20 4.36 ± 1.13 99.65 ± 1.00
PV-5 7.83 ± 0.56 0.69 ± 0.01 201.50 ± 3.17 6.10 4.34 ± 1.03 100.00 ± 0.20
PV-6 7.94 ± 0.63 0.62 ± 0.02 200.75 ± 3.32 8.13 4.30 ± 0.91 100.99 ± 1.10
PV-7 7.77 ± 0.51 0.53 ± 0.01 200.15 ± 2.25 11.17 4.34 ± 1.09 100.82 ± 1.08
PV-8 7.65 ± 0.65 0.46 ± 0.02 202.15 ± 1.32 14.00 4.31 ± 1.13 100.37 ± 1.46
All the values are expressed as mean±SD
TABLE VI - In vitro release of diclofenac sodium tablets 
Time (min) MN-1 MN-2 MN-3 MN-4 PV-1 PV-2 PV-3 PV-4
10 32.850 24.283 15.338 13.070 32.850 27.212 19.181 17.448
20 62.803 50.110 32.692 25.259 62.803 52.629 40.251 36.913
30 95.212 76.881 49.511 41.228 99.622 86.992 56.188 52.976
40 99.811 98.645 63.842 56.598 99.811 99.023 77.858 73.039
50 99.811 98.645 78.110 68.472 99.811 99.023 94.803 89.259
60 99.811 98.645 94.803 84.409 99.811 99.023 99.559 99.779
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By increasing the concentration (from 4% to 6%) of Mulva 
neglecta mucilage, the drug release retarded 8.56% in 
10 min. While concentration of PVP K30 (from 4% to 6%) 
showed drug release delayed 5.63%. By comparing drug 
release from tablets batches containing Mulva neglecta 
mucilage and PVP K30, it is clarified that release retarded 
by Mulva neglecta mucilage efficiently as compared to 
PVP K30.
Release kinetics
Different kinetic models (zero-order, first-order, 
Higuchi’s, Hixson Crowell and Korsmeyer’s equation) 
were applied to interpret the release profile (the order 
and mechanism of diclofenac sodium release) from 
tablet, as shown in Table VII. To study the mechanism 
of drug release from the tablets, the release data were 
fitted to zero-order, first-order, and Higuchi equation. 
However, two factors diminish the applicability of 
Higuchi’s equation to matrix systems. This model fails 
to allow the influence of swelling of the matrix (upon 
hydration) and gradual erosion of the matrix. Therefore, 
the dissolution data were also fitted according to the 
well-known exponential equation (Korsmeyer equation), 
which is often used to describe the drug release behaviour 
from polymeric systems. The Korsmeyer’s equation is 
given as follows:
where, Mt is the amount of drug release at time t, Mf is 
the amount of drug release after infinite time, k is release 
rate constant incorporating structural and geometric 
characteristics of the tablet and n is the diffusional 
exponent indicative of the mechanism of drug release.
To clarify the release exponent for different batches 
of matrix tablets, the log value of percentage drug 
dissolved was plotted against log time for each batch 
according to the Korsmeyer’s equation. A value of n = 0.45 
indicates Fickian (case I) release, > 0.45 but < 0.89 for 
non-Fickian (anomalous) release and > 0.89 indicates 
super case II type of release. Case II generally refers to the 
erosion of the polymeric chain and anomalous transport 
(non-Fickian) refers to a combination of both diffusion 
and erosion controlled-drug release (Gutti, Kalra, 2012).
Drug excipients compatibility studies
Drug and excipients compatibilities studies were 
carried out by using IR spectroscopy. IR Spectra of Drug 
(diclofenac sodium) and tablets formulations containing 
Mulva neglecta mucilage and tablet formulation blend 
were analyzed. The studies revealed that there was no 
significant interaction between drug and batches containing 
plant gums. The FT-IR spectrum of diclofenac sodium 
(drug) showed characteristic peaks at 3381.1, 3251.3, 
1588.2, 1501.3, 1442.7 and 1346.9 cm-1 as shown in 
Figure 2. Mulva neglecta mucilage showed characteristic 
peaks at 3247.3, 2927.8, 1600.8, 1416.9 and 1018.5 cm-1 
as shown in Figure 3. The FT-IR analysis of physical 
mixtures of diclofenac sodium including Mulva neglecta 
with other excipients is shown in Figure 4. Hence no major 
change in peaks of diclofenac sodium tablets formulations 
containing mucilage which confirm the compatibility 
of mucilage with drug and other excipients used.
TABLE VII - In vitro release kinetics of diclofenac sodium 
Tablets using Mulva neglecta mucilage as binder
Formulations
Zero Order First Order Higuchi Hixson Crowell Korsmeyer Release 
mechanismr2  r2  r2  r2  r2  N
MN-1 0.7410 0.6890 0.7180 0.8570 0.8090 0.535 non-Fickian
MN-2 0.8520 0.7790 0.8190 0.8810 0.8760 0.696 non-Fickian
MN-3 0.9980 0.9180 0.6370 0.9420 0.6430 0.446 Fickian
MN-4 0.9980 0.9380 0.9900 0.9360 0.9820 0.913 non-Fickian
PV-1 0.7020 0.6660 0.6810 0.7360 0.7890 0.534 non-Fickian
PV-2 0.8030 0.7440 0.8830 0.8760 0.9200 0.761 non-Fickian
PV-3 0.9780 0.8960 0.9784 0.9580 0.5820 0.399 Fickian
PV-4 0.9930 0.9120 0.9820 0.9130 0.9730 0.853 non-Fickian
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FIGURA 2 - FTIR Spectrum of diclofenac sodium.
FIGURA 3 - FTIR Spectrum of Mulva neglecta mucilage.
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CONCLUSIONS
These results showed that in comparison to PVP, the 
Mulva neglecta mucilage showed better binding capacity. 
It is concluded from the above study that Mulva neglecta 
mucilage is safe and can be used as binder in tablets 
formulation. 
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